Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection (Q39007700)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 February 2016
edit
Language Label Description Also known as
English
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection
scientific article published on 17 February 2016

    Statements

    Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection (English)
    17 February 2016

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit